ARTICLES

Filter  
Active filters 0
Remove
  

Refine your searches by:

Collections
Biology
Medicine / Sub specialtie
Public health
Medicine / Pharmacology
Research
Pure sciences
Chemistry
Economy
Social Sciences
Medicine / Surgery
all records (31)

Languages
English

Countries
USA
Italy
Pakistan
Indonesia
Macedonia
Bosnia Herzegovina
China
Canada
Ukraine
Bangladesh
all records (21)

Years
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
all records (15)

Filter  
 
96  Articles
1 of 11 pages  |  10  records  |  more records»
Objectives: To evaluate the clinical value of radiotherapy combined with Camrelizumab in treating locally advanced non-small cell lung cancer (NSCLC) patients.Methods: 80 locally advanced NSCLC patients were randomly divided into two groups (n=40). The co... see more

Immunotherapy is dramatically changing the therapeutic landscape of advanced Non Small Cell Lung Cancer (NSCLC), with unprecedented results compared with chemotherapy. However, this novel treatment approach poses several novel challenges, including optima... see more

With an incidence of 68 new cases per 100,000 people per year, an estimated total number of up to 350,000 new non-small-cell lung cancer (NSCLC) cases are diagnosed each year in the European Union. Up to 10% of NSCLC patients are eligible for therapy with... see more

Objectives: To evaluate the clinical effect of apatinib combined with chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC).Methods: Eighty patients with advanced NSCLC treated in Hebei General Hospital from January 2017 to July 202... see more

EGFR mutation rates in NSCLC differ among ethnic groups, nations, age, sex, smoking status, and histologic differentiation. We examined the clinicopathologic characteristics of EGFR mutations in NSCLC in the Central New York (CNY) region for the first tim... see more

Background: Chemotherapy and immunotherapy are the backbone for treatment of most NSCLC (non small cell lung cancer). But many patients are not able to tolerate chemotherapy and not able to afford immunotherapy in our scenario. Objective: The aim of this ... see more

Next Generation Sequencing (NGS) has become powerful tool in molecular oncology. It allows multiparallel targeted sequencing that enables comprehensive assessment of tumor heterogeneity. Detection of mutations in colorectal cancer (CRC) and non-small cell... see more

EGFR-TKI is the first-line therapy for EGFR-mutant patients. Nevertheless, patients will have disease progression (median PFS 10 – 12 months) due to resistance. The treatment options are still limited in developing countries for such cases, thus double-pl... see more

BACKGROUND: Advanced lung cancer is indicated with rapid disease development. Interleukin 27 (IL-27) is regarded as a cytokine with anti-tumour activities.AIM: Since, the impact of type of lung cancer on the level of IL-27 in patient’s serum has not yet b... see more

1 of 11 pages  |  10  records  |  more records»